Public awareness in the UK about non-melanoma skin cancer (NMSC) is 'worryingly low' and 'urgent action' is needed to improve sun protection for outdoor workers, concludes a new report by Sanofi.
Sirnaomics announced the U.S. Food and Drug Administration (FDA) has agreed to the company's proposed trial design for a Phase 2 clinical study to .....